StockData
Journey Medical Corp logo

Journey Medical Corp (DERM) stock

DERMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/3038% below fair value
$3.70−0.63 (-14.55%)

Close on Nov 16, 2026Market cap $104.43MP/E –Yield –

Journey Medical price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Journey Medical's price to sales ratio was 1.7× on Nov 11, 2026, against 3.1× a year earlier. Over the last 5 years it ranged from 0.3× to 3.2×, with a median of 1.3×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.7×−1.3
2025Dec 31, 20253.0×+1.7
2024Dec 31, 20241.3×−0.0
2023Dec 29, 20231.4×+1.0
2022Dec 30, 20220.4×+0.1
2021Dec 31, 20210.3×–

More Journey Medical figures

See a number that looks wrong?